Drug Strategies entered the industry of Research Institute in 1993 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 4461100, which describes it as a Research Institute. For further clarification, the SIC classifies this business under the code 8733 and described it as a Research Institute. The business provides service to the B2B market.
To acquire more information, please contact Mathea Falco, President by calling (202) 939-0664 during business hours. You can also write to the business’ Single Location at 1616 P St Nw # 220, Washington, District of Columbia DC 20036. You can also visit the company’s website at drugstrategies.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Drug Strategies |
Representative: | Mathea Falco, President |
Place of Business: | 1616 P St Nw # 220, Washington, DC 20036 |
Contact Number: | (202) 939-0664 |
Website: | drugstrategies.com |
Type of Service: | Research Institute |
SIC Number: | 8733 |
NAICS Number: | 4461100 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1993 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Drug Strategies is a company operating from District of Columbia, District of Columbia providing professional Research Institute and relevant B2B variables. It was founded in 1993 and registered with the SIC code 8733 as Research Institute, and with the NAICS code 4461100 as Research Institute.
With a current employee count of 1 to 4, Drug Strategies has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Mathea Falco, President at (202) 939-0664 for related queries, or to locate its Single Location using the coordinates 38.90958,-77.03772.
The Single Location can also be found at the street address 1616 P St Nw # 220 in Washington, District of Columbia 20036 and can be engaged online through the company website at drugstrategies.com, the company Twitter , and Facebook page .